Functional lung avoidance for individualized radiotherapy (FLAIR): Study protocol for a randomized, double-blind clinical trial

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Hoover, Douglas A ^a,b   Capaldi, Dante P I ^b,c   Sheikh, Khadija ^b,c   Palma, David A ^a,b   Rodrigues, George B ^a,b   Dar, A Rashid ^a   Yu, Edward ^a   Dingle, Brian ^a   Landis, Mark ^b   Kocha, Walter ^b   Sanatani, Michael ^b   Vincent, Mark ^b   Younus, Jawaid ^b   Kuruvilla, Sara ^b   Gaede, Stewart ^a,b   Parraga, Grace ^b,c   Yaremko, Brian P ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Functional imaging; Helium 3 MRI; Non small cell lung cancer; Quality of life; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FUNCTIONAL ASSESSMENT; FUNCTIONAL LUNG AVOIDANCE FOR INDIVIDUALIZED RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROCESS OPTIMIZATION; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 84928745613     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-934     Document Type: Article

References (33)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr.
2. Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD: Radiotherapy plus chemotherapy with or without surgical resection for stage III non-smallcell lung cancer: a phase III randomised controlled trial. Lancet 2009, 374(9687):379-386.
3. van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giacconne G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007, 99(6):442-450.
4. O'Rourke N, Roque IFM, Farre Bernado N, Macbeth F: Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2010, 6:CD002140.
5. Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD: Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011, 103(19):1452-1460.
6. Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J: Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review. Radiother Oncol 2004, 71(2):127-138.
7. Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, Bradley JD, Kim TH, Ramella S, Marks LB, De Petris L, Stitt L, Rodrigues G: Predicting radiation pneumonitis after chemoradiotherapy for lung cancer: an international individual patient data meta-analysis submitted, under review. Int J Radiat Oncol Biol Phys 2011, 85(2):444-450.
8. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, Kado T, Takada Y: Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2003, 55(1):110-115.
9. Movsas B, Hu C, Sloan J, Bradley JD, Kavadi VS, Narayan S, Robinson C, Johnson DW, Paulus R, Choy H: Quality of life (QOL) analysis of the randomized radiation (RT) dose-escalation NSCLC trial (RTOG 0617): the rest of the story. Int J Radiat Oncol Biol Phys 2013, 87(2):S1-S2.
10. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R: Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 68(5):1349-1358.
11. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R: Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys 2007, 68(2):562-571.
12. Ding K, Bayouth JE, Buatti JM, Christensen GE, Reinhardt JM: 4DCT-based measurement of changes in pulmonary function following a course of radiation therapy. Med Phys 2010, 37(3):1261-1272.
13. Vinogradskiy YY, Castillo R, Castillo E, Chandler A, Martel MK, Guerrero T: Use of weekly 4DCT-based ventilation maps to quantify changes in lung function for patients undergoing radiation therapy. Med Phys 2012, 39(1):289-298.
14. Hodge CW, Tome WA, Fain SB, Bentzen SM, Mehta MP: On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy. Med Dosim 2010, 35(4):297-303.
15. Ireland RH, Bragg CM, McJury M, Woodhouse N, Fichele S, van Beek EJ, Wild JM, Hatton MQ: Feasibility of image registration and intensitymodulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 68(1):273-281.
16. Lavrenkov K, Singh S, Christian JA, Partridge M, Nioutsikou E, Cook G, Bedford JL, Brada M: Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. Radiother Oncol 2009, 91(3):349-352.
17. Jogi J, Jonson B, Ekberg M, Bajc M: Ventilation-perfusion SPECT with 99mTc-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med 2010, 51(5):735-741.
18. Mathew L, Gaede S, Wheatley A, Etemad-Rezai R, Rodrigues GB, Parraga G: Detection of longitudinal lung structural and functional changes after diagnosis of radiation-induced lung injury using hyperpolarized 3He magnetic resonance imaging. Med Phys 2010, 37(1):22-31.
19. Fain S, Schiebler ML, McCormack DG, Parraga G: Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: Review of current and emerging translational methods and applications. J Magn Reson Imaging 2010, 32(6):1398-1408.
20. Patz S, Muradian I, Hrovat MI, Ruset IC, Topulos G, Covrig SD, Frederick E, Hatabu H, Hersman FW, Butler JP: Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T. Acad Radiol 2008, 15(6):713-727.
21. Bauman G, Puderbach M, Deimling M, Jellus V, Chefd'hotel C, Dinkel J, Hintze C, Kauczor HU, Schad LR: Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 2009, 62(3):656-664.
22. Mathew L, Wheatley A, Castillo R, Castillo E, Rodrigues G, Guerrero T, Parraga G: Hyperpolarized 3He magnetic resonance imaging: comparison with four-dimensional x-ray computed tomography imaging in lung cancer. Acad Radiol 2012, 19(12):1546-1553.
23. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: General considerations for lung function testing. Eur Respir J 2005, 26(1):153-161.
24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338.
25. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968.
26. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J 2005, 26(3):511-522.
27. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CPM, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26(4):720-735.
28. AmericanThoracicSociety: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111-117.
29. Siegl P, Schultz K: The Borg scale as an instrument for the detection of subjectively experienced stress in industrial medicine laboratory and field studies. Z Gesamte Hyg 1984, 30(7):383-386.
30. Parraga G, Ouriadov A, Evans A, McKay S, Lam WW, Fenster A, Etemad-Rezai R, McCormack D, Santyr G: Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol 2007, 42(6):384-391.
31. Protocol: RTOG 0617. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0617.
32. Cella D, Eton DT, Fairclough DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH: What is a clinically meaningful change on the functional assessment of cancer therapy-lung (FACT-L) questionnaire? Results from eastern cooperative oncology group (ECOG) study 5592. J Clin Epidemiol 2002, 55(3):285-295.
33. Auchter RM, Scholtens D, Adak S, Wagner H, Cella DF, Mehta MP: Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593 Eastern cooperative oncology group. Int J Radiat Oncol Biol Phys 2001, 50(5):1199-1206.